Insider Transactions in Q1 2025 at Insmed Inc (INSM)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 08
2025
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
22,824
+5.46%
|
-
|
|
Jan 08
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,999
-1.06%
|
$259,935
$65.96 P/Share
|
|
Jan 08
2025
|
John Drayton Wise Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,657
+5.02%
|
-
|
|
Jan 08
2025
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
392
-0.33%
|
$25,872
$66.21 P/Share
|
|
Jan 08
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,706
+5.3%
|
-
|
|
Jan 08
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,209
-1.24%
|
$78,585
$65.84 P/Share
|
|
Jan 08
2025
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,657
+5.26%
|
-
|
|
Jan 08
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,464
-1.28%
|
$96,624
$66.05 P/Share
|
|
Jan 08
2025
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,657
+5.82%
|
-
|
|
Jan 08
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,702
-1.66%
|
$112,332
$66.16 P/Share
|
|
Jan 08
2025
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,706
+7.51%
|
-
|
|
Jan 08
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
1,064
-1.62%
|
$70,224
$66.21 P/Share
|
|
Jan 07
2025
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
2,444
-1.63%
|
$158,860
$65.95 P/Share
|
|
Jan 07
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
8,218
-2.13%
|
$542,388
$66.02 P/Share
|
|
Jan 07
2025
|
John Drayton Wise Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,908
-4.96%
|
$839,020
$65.93 P/Share
|
|
Jan 07
2025
|
John Drayton Wise Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+7.02%
|
$160,000
$16.07 P/Share
|
|
Jan 07
2025
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
2,596
-2.59%
|
$168,740
$65.88 P/Share
|
|
Jan 07
2025
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,470
-2.94%
|
$225,550
$65.7 P/Share
|
|
Jan 07
2025
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,344
-3.15%
|
$217,360
$65.91 P/Share
|
|
Jan 07
2025
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,306
-3.39%
|
$149,890
$65.98 P/Share
|
|
Jan 02
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Indirect |
6,830
-2.84%
|
$471,270
$69.86 P/Share
|
|
Jan 02
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
6,830
+2.76%
|
$68,300
$10.85 P/Share
|
|
Jan 02
2025
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
18,750
-4.64%
|
$1,293,750
$69.84 P/Share
|
|
Jan 02
2025
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
18,750
+4.44%
|
$412,500
$22.76 P/Share
|